Global Sialylated Human Milk Oligosaccharides (HMO) Supply, Demand and Key Producers, 2024-2030
Page: 100
Published Date: 07 Feb 2024
Category: Food & Beverages
PDF Download
Get FREE Sample
Customize Request
- Description
- Table of Contents
- Table of Figures
- Research Methodology
- Companies Mentioned
- Related Reports
- Product Tags
Description
The global Sialylated Human Milk Oligosaccharides (HMO) market size is expected to reach $ million by 2030, rising at a market growth of % CAGR during the forecast period (2024-2030).
Sialylated HMOs are an important type of HMOs, accounting for approximately 13% of total HMOs. 3’-Sialyllactose (3’-SL) and 6′-sialyllactose (6’-SL) are two simplest sialylated HMOs. The global market for Human Milk Oligosaccharides (HMO) was estimated to be worth US$ 467.7 million in 2023 and is forecast to a readjusted size of US$ 1227.5 million by 2030 with a CAGR of 14.5% during the forecast period 2024-2030.
This report studies the global Sialylated Human Milk Oligosaccharides (HMO) production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Sialylated Human Milk Oligosaccharides (HMO), and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2023 as the base year. This report explores demand trends and competition, as well as details the characteristics of Sialylated Human Milk Oligosaccharides (HMO) that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Sialylated Human Milk Oligosaccharides (HMO) total production and demand, 2019-2030, (Tons)
Global Sialylated Human Milk Oligosaccharides (HMO) total production value, 2019-2030, (USD Million)
Global Sialylated Human Milk Oligosaccharides (HMO) production by region & country, production, value, CAGR, 2019-2030, (USD Million) & (Tons)
Global Sialylated Human Milk Oligosaccharides (HMO) consumption by region & country, CAGR, 2019-2030 & (Tons)
U.S. VS China: Sialylated Human Milk Oligosaccharides (HMO) domestic production, consumption, key domestic manufacturers and share
Global Sialylated Human Milk Oligosaccharides (HMO) production by manufacturer, production, price, value and market share 2019-2024, (USD Million) & (Tons)
Global Sialylated Human Milk Oligosaccharides (HMO) production by Type, production, value, CAGR, 2019-2030, (USD Million) & (Tons)
Global Sialylated Human Milk Oligosaccharides (HMO) production by Application production, value, CAGR, 2019-2030, (USD Million) & (Tons).
This reports profiles key players in the global Sialylated Human Milk Oligosaccharides (HMO) market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Chr. Hansen (Jennewein Biotechnologie GmgH), DSM (Glycom A/S), Inbiose, Kyowa Hakko Bio, GeneChem Inc. and FrieslandCampina Ingredients, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Sialylated Human Milk Oligosaccharides (HMO) market.
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (Tons) and average price (US$/Kg) by manufacturer, by Type, and by Application. Data is given for the years 2019-2030 by year with 2023 as the base year, 2024 as the estimate year, and 2025-2030 as the forecast year.
Global Sialylated Human Milk Oligosaccharides (HMO) Market, By Region:
United States
China
Europe
Japan
South Korea
ASEAN
India
Rest of World
Global Sialylated Human Milk Oligosaccharides (HMO) Market, Segmentation by Type
3'-Sialyllactose
6'-Sialyllactose
Global Sialylated Human Milk Oligosaccharides (HMO) Market, Segmentation by Application
Infant Formula
Food
Others
Companies Profiled:
Chr. Hansen (Jennewein Biotechnologie GmgH)
DSM (Glycom A/S)
Inbiose
Kyowa Hakko Bio
GeneChem Inc.
FrieslandCampina Ingredients
Key Questions Answered
1. How big is the global Sialylated Human Milk Oligosaccharides (HMO) market?
2. What is the demand of the global Sialylated Human Milk Oligosaccharides (HMO) market?
3. What is the year over year growth of the global Sialylated Human Milk Oligosaccharides (HMO) market?
4. What is the production and production value of the global Sialylated Human Milk Oligosaccharides (HMO) market?
5. Who are the key producers in the global Sialylated Human Milk Oligosaccharides (HMO) market?
Table of Contents
1 Supply Summary
1.1 Sialylated Human Milk Oligosaccharides (HMO) Introduction
1.2 World Sialylated Human Milk Oligosaccharides (HMO) Supply & Forecast
1.2.1 World Sialylated Human Milk Oligosaccharides (HMO) Production Value (2019 & 2023 & 2030)
1.2.2 World Sialylated Human Milk Oligosaccharides (HMO) Production (2019-2030)
1.2.3 World Sialylated Human Milk Oligosaccharides (HMO) Pricing Trends (2019-2030)
1.3 World Sialylated Human Milk Oligosaccharides (HMO) Production by Region (Based on Production Site)
1.3.1 World Sialylated Human Milk Oligosaccharides (HMO) Production Value by Region (2019-2030)
1.3.2 World Sialylated Human Milk Oligosaccharides (HMO) Production by Region (2019-2030)
1.3.3 World Sialylated Human Milk Oligosaccharides (HMO) Average Price by Region (2019-2030)
1.3.4 North America Sialylated Human Milk Oligosaccharides (HMO) Production (2019-2030)
1.3.5 Europe Sialylated Human Milk Oligosaccharides (HMO) Production (2019-2030)
1.3.6 China Sialylated Human Milk Oligosaccharides (HMO) Production (2019-2030)
1.3.7 Japan Sialylated Human Milk Oligosaccharides (HMO) Production (2019-2030)
1.4 Market Drivers, Restraints and Trends
1.4.1 Sialylated Human Milk Oligosaccharides (HMO) Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Sialylated Human Milk Oligosaccharides (HMO) Major Market Trends
2 Demand Summary
2.1 World Sialylated Human Milk Oligosaccharides (HMO) Demand (2019-2030)
2.2 World Sialylated Human Milk Oligosaccharides (HMO) Consumption by Region
2.2.1 World Sialylated Human Milk Oligosaccharides (HMO) Consumption by Region (2019-2024)
2.2.2 World Sialylated Human Milk Oligosaccharides (HMO) Consumption Forecast by Region (2025-2030)
2.3 United States Sialylated Human Milk Oligosaccharides (HMO) Consumption (2019-2030)
2.4 China Sialylated Human Milk Oligosaccharides (HMO) Consumption (2019-2030)
2.5 Europe Sialylated Human Milk Oligosaccharides (HMO) Consumption (2019-2030)
2.6 Japan Sialylated Human Milk Oligosaccharides (HMO) Consumption (2019-2030)
2.7 South Korea Sialylated Human Milk Oligosaccharides (HMO) Consumption (2019-2030)
2.8 ASEAN Sialylated Human Milk Oligosaccharides (HMO) Consumption (2019-2030)
2.9 India Sialylated Human Milk Oligosaccharides (HMO) Consumption (2019-2030)
3 World Sialylated Human Milk Oligosaccharides (HMO) Manufacturers Competitive Analysis
3.1 World Sialylated Human Milk Oligosaccharides (HMO) Production Value by Manufacturer (2019-2024)
3.2 World Sialylated Human Milk Oligosaccharides (HMO) Production by Manufacturer (2019-2024)
3.3 World Sialylated Human Milk Oligosaccharides (HMO) Average Price by Manufacturer (2019-2024)
3.4 Sialylated Human Milk Oligosaccharides (HMO) Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Sialylated Human Milk Oligosaccharides (HMO) Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Sialylated Human Milk Oligosaccharides (HMO) in 2023
3.5.3 Global Concentration Ratios (CR8) for Sialylated Human Milk Oligosaccharides (HMO) in 2023
3.6 Sialylated Human Milk Oligosaccharides (HMO) Market: Overall Company Footprint Analysis
3.6.1 Sialylated Human Milk Oligosaccharides (HMO) Market: Region Footprint
3.6.2 Sialylated Human Milk Oligosaccharides (HMO) Market: Company Product Type Footprint
3.6.3 Sialylated Human Milk Oligosaccharides (HMO) Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 United States VS China VS Rest of the World
4.1 United States VS China: Sialylated Human Milk Oligosaccharides (HMO) Production Value Comparison
4.1.1 United States VS China: Sialylated Human Milk Oligosaccharides (HMO) Production Value Comparison (2019 & 2023 & 2030)
4.1.2 United States VS China: Sialylated Human Milk Oligosaccharides (HMO) Production Value Market Share Comparison (2019 & 2023 & 2030)
4.2 United States VS China: Sialylated Human Milk Oligosaccharides (HMO) Production Comparison
4.2.1 United States VS China: Sialylated Human Milk Oligosaccharides (HMO) Production Comparison (2019 & 2023 & 2030)
4.2.2 United States VS China: Sialylated Human Milk Oligosaccharides (HMO) Production Market Share Comparison (2019 & 2023 & 2030)
4.3 United States VS China: Sialylated Human Milk Oligosaccharides (HMO) Consumption Comparison
4.3.1 United States VS China: Sialylated Human Milk Oligosaccharides (HMO) Consumption Comparison (2019 & 2023 & 2030)
4.3.2 United States VS China: Sialylated Human Milk Oligosaccharides (HMO) Consumption Market Share Comparison (2019 & 2023 & 2030)
4.4 United States Based Sialylated Human Milk Oligosaccharides (HMO) Manufacturers and Market Share, 2019-2024
4.4.1 United States Based Sialylated Human Milk Oligosaccharides (HMO) Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Sialylated Human Milk Oligosaccharides (HMO) Production Value (2019-2024)
4.4.3 United States Based Manufacturers Sialylated Human Milk Oligosaccharides (HMO) Production (2019-2024)
4.5 China Based Sialylated Human Milk Oligosaccharides (HMO) Manufacturers and Market Share
4.5.1 China Based Sialylated Human Milk Oligosaccharides (HMO) Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Sialylated Human Milk Oligosaccharides (HMO) Production Value (2019-2024)
4.5.3 China Based Manufacturers Sialylated Human Milk Oligosaccharides (HMO) Production (2019-2024)
4.6 Rest of World Based Sialylated Human Milk Oligosaccharides (HMO) Manufacturers and Market Share, 2019-2024
4.6.1 Rest of World Based Sialylated Human Milk Oligosaccharides (HMO) Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Sialylated Human Milk Oligosaccharides (HMO) Production Value (2019-2024)
4.6.3 Rest of World Based Manufacturers Sialylated Human Milk Oligosaccharides (HMO) Production (2019-2024)
5 Market Analysis by Type
5.1 World Sialylated Human Milk Oligosaccharides (HMO) Market Size Overview by Type: 2019 VS 2023 VS 2030
5.2 Segment Introduction by Type
5.2.1 3'-Sialyllactose
5.2.2 6'-Sialyllactose
5.3 Market Segment by Type
5.3.1 World Sialylated Human Milk Oligosaccharides (HMO) Production by Type (2019-2030)
5.3.2 World Sialylated Human Milk Oligosaccharides (HMO) Production Value by Type (2019-2030)
5.3.3 World Sialylated Human Milk Oligosaccharides (HMO) Average Price by Type (2019-2030)
6 Market Analysis by Application
6.1 World Sialylated Human Milk Oligosaccharides (HMO) Market Size Overview by Application: 2019 VS 2023 VS 2030
6.2 Segment Introduction by Application
6.2.1 Infant Formula
6.2.2 Food
6.2.3 Others
6.3 Market Segment by Application
6.3.1 World Sialylated Human Milk Oligosaccharides (HMO) Production by Application (2019-2030)
6.3.2 World Sialylated Human Milk Oligosaccharides (HMO) Production Value by Application (2019-2030)
6.3.3 World Sialylated Human Milk Oligosaccharides (HMO) Average Price by Application (2019-2030)
7 Company Profiles
7.1 Chr. Hansen (Jennewein Biotechnologie GmgH)
7.1.1 Chr. Hansen (Jennewein Biotechnologie GmgH) Details
7.1.2 Chr. Hansen (Jennewein Biotechnologie GmgH) Major Business
7.1.3 Chr. Hansen (Jennewein Biotechnologie GmgH) Sialylated Human Milk Oligosaccharides (HMO) Product and Services
7.1.4 Chr. Hansen (Jennewein Biotechnologie GmgH) Sialylated Human Milk Oligosaccharides (HMO) Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.1.5 Chr. Hansen (Jennewein Biotechnologie GmgH) Recent Developments/Updates
7.1.6 Chr. Hansen (Jennewein Biotechnologie GmgH) Competitive Strengths & Weaknesses
7.2 DSM (Glycom A/S)
7.2.1 DSM (Glycom A/S) Details
7.2.2 DSM (Glycom A/S) Major Business
7.2.3 DSM (Glycom A/S) Sialylated Human Milk Oligosaccharides (HMO) Product and Services
7.2.4 DSM (Glycom A/S) Sialylated Human Milk Oligosaccharides (HMO) Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.2.5 DSM (Glycom A/S) Recent Developments/Updates
7.2.6 DSM (Glycom A/S) Competitive Strengths & Weaknesses
7.3 Inbiose
7.3.1 Inbiose Details
7.3.2 Inbiose Major Business
7.3.3 Inbiose Sialylated Human Milk Oligosaccharides (HMO) Product and Services
7.3.4 Inbiose Sialylated Human Milk Oligosaccharides (HMO) Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.3.5 Inbiose Recent Developments/Updates
7.3.6 Inbiose Competitive Strengths & Weaknesses
7.4 Kyowa Hakko Bio
7.4.1 Kyowa Hakko Bio Details
7.4.2 Kyowa Hakko Bio Major Business
7.4.3 Kyowa Hakko Bio Sialylated Human Milk Oligosaccharides (HMO) Product and Services
7.4.4 Kyowa Hakko Bio Sialylated Human Milk Oligosaccharides (HMO) Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.4.5 Kyowa Hakko Bio Recent Developments/Updates
7.4.6 Kyowa Hakko Bio Competitive Strengths & Weaknesses
7.5 GeneChem Inc.
7.5.1 GeneChem Inc. Details
7.5.2 GeneChem Inc. Major Business
7.5.3 GeneChem Inc. Sialylated Human Milk Oligosaccharides (HMO) Product and Services
7.5.4 GeneChem Inc. Sialylated Human Milk Oligosaccharides (HMO) Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.5.5 GeneChem Inc. Recent Developments/Updates
7.5.6 GeneChem Inc. Competitive Strengths & Weaknesses
7.6 FrieslandCampina Ingredients
7.6.1 FrieslandCampina Ingredients Details
7.6.2 FrieslandCampina Ingredients Major Business
7.6.3 FrieslandCampina Ingredients Sialylated Human Milk Oligosaccharides (HMO) Product and Services
7.6.4 FrieslandCampina Ingredients Sialylated Human Milk Oligosaccharides (HMO) Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.6.5 FrieslandCampina Ingredients Recent Developments/Updates
7.6.6 FrieslandCampina Ingredients Competitive Strengths & Weaknesses
8 Industry Chain Analysis
8.1 Sialylated Human Milk Oligosaccharides (HMO) Industry Chain
8.2 Sialylated Human Milk Oligosaccharides (HMO) Upstream Analysis
8.2.1 Sialylated Human Milk Oligosaccharides (HMO) Core Raw Materials
8.2.2 Main Manufacturers of Sialylated Human Milk Oligosaccharides (HMO) Core Raw Materials
8.3 Midstream Analysis
8.4 Downstream Analysis
8.5 Sialylated Human Milk Oligosaccharides (HMO) Production Mode
8.6 Sialylated Human Milk Oligosaccharides (HMO) Procurement Model
8.7 Sialylated Human Milk Oligosaccharides (HMO) Industry Sales Model and Sales Channels
8.7.1 Sialylated Human Milk Oligosaccharides (HMO) Sales Model
8.7.2 Sialylated Human Milk Oligosaccharides (HMO) Typical Customers
9 Research Findings and Conclusion
10 Appendix
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
Table of Figures
List of Tables
Table 1. World Sialylated Human Milk Oligosaccharides (HMO) Production Value by Region (2019, 2023 and 2030) & (USD Million)
Table 2. World Sialylated Human Milk Oligosaccharides (HMO) Production Value by Region (2019-2024) & (USD Million)
Table 3. World Sialylated Human Milk Oligosaccharides (HMO) Production Value by Region (2025-2030) & (USD Million)
Table 4. World Sialylated Human Milk Oligosaccharides (HMO) Production Value Market Share by Region (2019-2024)
Table 5. World Sialylated Human Milk Oligosaccharides (HMO) Production Value Market Share by Region (2025-2030)
Table 6. World Sialylated Human Milk Oligosaccharides (HMO) Production by Region (2019-2024) & (Tons)
Table 7. World Sialylated Human Milk Oligosaccharides (HMO) Production by Region (2025-2030) & (Tons)
Table 8. World Sialylated Human Milk Oligosaccharides (HMO) Production Market Share by Region (2019-2024)
Table 9. World Sialylated Human Milk Oligosaccharides (HMO) Production Market Share by Region (2025-2030)
Table 10. World Sialylated Human Milk Oligosaccharides (HMO) Average Price by Region (2019-2024) & (US$/Kg)
Table 11. World Sialylated Human Milk Oligosaccharides (HMO) Average Price by Region (2025-2030) & (US$/Kg)
Table 12. Sialylated Human Milk Oligosaccharides (HMO) Major Market Trends
Table 13. World Sialylated Human Milk Oligosaccharides (HMO) Consumption Growth Rate Forecast by Region (2019 & 2023 & 2030) & (Tons)
Table 14. World Sialylated Human Milk Oligosaccharides (HMO) Consumption by Region (2019-2024) & (Tons)
Table 15. World Sialylated Human Milk Oligosaccharides (HMO) Consumption Forecast by Region (2025-2030) & (Tons)
Table 16. World Sialylated Human Milk Oligosaccharides (HMO) Production Value by Manufacturer (2019-2024) & (USD Million)
Table 17. Production Value Market Share of Key Sialylated Human Milk Oligosaccharides (HMO) Producers in 2023
Table 18. World Sialylated Human Milk Oligosaccharides (HMO) Production by Manufacturer (2019-2024) & (Tons)
Table 19. Production Market Share of Key Sialylated Human Milk Oligosaccharides (HMO) Producers in 2023
Table 20. World Sialylated Human Milk Oligosaccharides (HMO) Average Price by Manufacturer (2019-2024) & (US$/Kg)
Table 21. Global Sialylated Human Milk Oligosaccharides (HMO) Company Evaluation Quadrant
Table 22. World Sialylated Human Milk Oligosaccharides (HMO) Industry Rank of Major Manufacturers, Based on Production Value in 2023
Table 23. Head Office and Sialylated Human Milk Oligosaccharides (HMO) Production Site of Key Manufacturer
Table 24. Sialylated Human Milk Oligosaccharides (HMO) Market: Company Product Type Footprint
Table 25. Sialylated Human Milk Oligosaccharides (HMO) Market: Company Product Application Footprint
Table 26. Sialylated Human Milk Oligosaccharides (HMO) Competitive Factors
Table 27. Sialylated Human Milk Oligosaccharides (HMO) New Entrant and Capacity Expansion Plans
Table 28. Sialylated Human Milk Oligosaccharides (HMO) Mergers & Acquisitions Activity
Table 29. United States VS China Sialylated Human Milk Oligosaccharides (HMO) Production Value Comparison, (2019 & 2023 & 2030) & (USD Million)
Table 30. United States VS China Sialylated Human Milk Oligosaccharides (HMO) Production Comparison, (2019 & 2023 & 2030) & (Tons)
Table 31. United States VS China Sialylated Human Milk Oligosaccharides (HMO) Consumption Comparison, (2019 & 2023 & 2030) & (Tons)
Table 32. United States Based Sialylated Human Milk Oligosaccharides (HMO) Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Sialylated Human Milk Oligosaccharides (HMO) Production Value, (2019-2024) & (USD Million)
Table 34. United States Based Manufacturers Sialylated Human Milk Oligosaccharides (HMO) Production Value Market Share (2019-2024)
Table 35. United States Based Manufacturers Sialylated Human Milk Oligosaccharides (HMO) Production (2019-2024) & (Tons)
Table 36. United States Based Manufacturers Sialylated Human Milk Oligosaccharides (HMO) Production Market Share (2019-2024)
Table 37. China Based Sialylated Human Milk Oligosaccharides (HMO) Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Sialylated Human Milk Oligosaccharides (HMO) Production Value, (2019-2024) & (USD Million)
Table 39. China Based Manufacturers Sialylated Human Milk Oligosaccharides (HMO) Production Value Market Share (2019-2024)
Table 40. China Based Manufacturers Sialylated Human Milk Oligosaccharides (HMO) Production (2019-2024) & (Tons)
Table 41. China Based Manufacturers Sialylated Human Milk Oligosaccharides (HMO) Production Market Share (2019-2024)
Table 42. Rest of World Based Sialylated Human Milk Oligosaccharides (HMO) Manufacturers, Headquarters and Production Site (States, Country)
Table 43. Rest of World Based Manufacturers Sialylated Human Milk Oligosaccharides (HMO) Production Value, (2019-2024) & (USD Million)
Table 44. Rest of World Based Manufacturers Sialylated Human Milk Oligosaccharides (HMO) Production Value Market Share (2019-2024)
Table 45. Rest of World Based Manufacturers Sialylated Human Milk Oligosaccharides (HMO) Production (2019-2024) & (Tons)
Table 46. Rest of World Based Manufacturers Sialylated Human Milk Oligosaccharides (HMO) Production Market Share (2019-2024)
Table 47. World Sialylated Human Milk Oligosaccharides (HMO) Production Value by Type, (USD Million), 2019 & 2023 & 2030
Table 48. World Sialylated Human Milk Oligosaccharides (HMO) Production by Type (2019-2024) & (Tons)
Table 49. World Sialylated Human Milk Oligosaccharides (HMO) Production by Type (2025-2030) & (Tons)
Table 50. World Sialylated Human Milk Oligosaccharides (HMO) Production Value by Type (2019-2024) & (USD Million)
Table 51. World Sialylated Human Milk Oligosaccharides (HMO) Production Value by Type (2025-2030) & (USD Million)
Table 52. World Sialylated Human Milk Oligosaccharides (HMO) Average Price by Type (2019-2024) & (US$/Kg)
Table 53. World Sialylated Human Milk Oligosaccharides (HMO) Average Price by Type (2025-2030) & (US$/Kg)
Table 54. World Sialylated Human Milk Oligosaccharides (HMO) Production Value by Application, (USD Million), 2019 & 2023 & 2030
Table 55. World Sialylated Human Milk Oligosaccharides (HMO) Production by Application (2019-2024) & (Tons)
Table 56. World Sialylated Human Milk Oligosaccharides (HMO) Production by Application (2025-2030) & (Tons)
Table 57. World Sialylated Human Milk Oligosaccharides (HMO) Production Value by Application (2019-2024) & (USD Million)
Table 58. World Sialylated Human Milk Oligosaccharides (HMO) Production Value by Application (2025-2030) & (USD Million)
Table 59. World Sialylated Human Milk Oligosaccharides (HMO) Average Price by Application (2019-2024) & (US$/Kg)
Table 60. World Sialylated Human Milk Oligosaccharides (HMO) Average Price by Application (2025-2030) & (US$/Kg)
Table 61. Chr. Hansen (Jennewein Biotechnologie GmgH) Basic Information, Manufacturing Base and Competitors
Table 62. Chr. Hansen (Jennewein Biotechnologie GmgH) Major Business
Table 63. Chr. Hansen (Jennewein Biotechnologie GmgH) Sialylated Human Milk Oligosaccharides (HMO) Product and Services
Table 64. Chr. Hansen (Jennewein Biotechnologie GmgH) Sialylated Human Milk Oligosaccharides (HMO) Production (Tons), Price (US$/Kg), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 65. Chr. Hansen (Jennewein Biotechnologie GmgH) Recent Developments/Updates
Table 66. Chr. Hansen (Jennewein Biotechnologie GmgH) Competitive Strengths & Weaknesses
Table 67. DSM (Glycom A/S) Basic Information, Manufacturing Base and Competitors
Table 68. DSM (Glycom A/S) Major Business
Table 69. DSM (Glycom A/S) Sialylated Human Milk Oligosaccharides (HMO) Product and Services
Table 70. DSM (Glycom A/S) Sialylated Human Milk Oligosaccharides (HMO) Production (Tons), Price (US$/Kg), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 71. DSM (Glycom A/S) Recent Developments/Updates
Table 72. DSM (Glycom A/S) Competitive Strengths & Weaknesses
Table 73. Inbiose Basic Information, Manufacturing Base and Competitors
Table 74. Inbiose Major Business
Table 75. Inbiose Sialylated Human Milk Oligosaccharides (HMO) Product and Services
Table 76. Inbiose Sialylated Human Milk Oligosaccharides (HMO) Production (Tons), Price (US$/Kg), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 77. Inbiose Recent Developments/Updates
Table 78. Inbiose Competitive Strengths & Weaknesses
Table 79. Kyowa Hakko Bio Basic Information, Manufacturing Base and Competitors
Table 80. Kyowa Hakko Bio Major Business
Table 81. Kyowa Hakko Bio Sialylated Human Milk Oligosaccharides (HMO) Product and Services
Table 82. Kyowa Hakko Bio Sialylated Human Milk Oligosaccharides (HMO) Production (Tons), Price (US$/Kg), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 83. Kyowa Hakko Bio Recent Developments/Updates
Table 84. Kyowa Hakko Bio Competitive Strengths & Weaknesses
Table 85. GeneChem Inc. Basic Information, Manufacturing Base and Competitors
Table 86. GeneChem Inc. Major Business
Table 87. GeneChem Inc. Sialylated Human Milk Oligosaccharides (HMO) Product and Services
Table 88. GeneChem Inc. Sialylated Human Milk Oligosaccharides (HMO) Production (Tons), Price (US$/Kg), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 89. GeneChem Inc. Recent Developments/Updates
Table 90. FrieslandCampina Ingredients Basic Information, Manufacturing Base and Competitors
Table 91. FrieslandCampina Ingredients Major Business
Table 92. FrieslandCampina Ingredients Sialylated Human Milk Oligosaccharides (HMO) Product and Services
Table 93. FrieslandCampina Ingredients Sialylated Human Milk Oligosaccharides (HMO) Production (Tons), Price (US$/Kg), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 94. Global Key Players of Sialylated Human Milk Oligosaccharides (HMO) Upstream (Raw Materials)
Table 95. Sialylated Human Milk Oligosaccharides (HMO) Typical Customers
Table 96. Sialylated Human Milk Oligosaccharides (HMO) Typical Distributors
List of Figure
Figure 1. Sialylated Human Milk Oligosaccharides (HMO) Picture
Figure 2. World Sialylated Human Milk Oligosaccharides (HMO) Production Value: 2019 & 2023 & 2030, (USD Million)
Figure 3. World Sialylated Human Milk Oligosaccharides (HMO) Production Value and Forecast (2019-2030) & (USD Million)
Figure 4. World Sialylated Human Milk Oligosaccharides (HMO) Production (2019-2030) & (Tons)
Figure 5. World Sialylated Human Milk Oligosaccharides (HMO) Average Price (2019-2030) & (US$/Kg)
Figure 6. World Sialylated Human Milk Oligosaccharides (HMO) Production Value Market Share by Region (2019-2030)
Figure 7. World Sialylated Human Milk Oligosaccharides (HMO) Production Market Share by Region (2019-2030)
Figure 8. North America Sialylated Human Milk Oligosaccharides (HMO) Production (2019-2030) & (Tons)
Figure 9. Europe Sialylated Human Milk Oligosaccharides (HMO) Production (2019-2030) & (Tons)
Figure 10. China Sialylated Human Milk Oligosaccharides (HMO) Production (2019-2030) & (Tons)
Figure 11. Japan Sialylated Human Milk Oligosaccharides (HMO) Production (2019-2030) & (Tons)
Figure 12. Sialylated Human Milk Oligosaccharides (HMO) Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Sialylated Human Milk Oligosaccharides (HMO) Consumption (2019-2030) & (Tons)
Figure 15. World Sialylated Human Milk Oligosaccharides (HMO) Consumption Market Share by Region (2019-2030)
Figure 16. United States Sialylated Human Milk Oligosaccharides (HMO) Consumption (2019-2030) & (Tons)
Figure 17. China Sialylated Human Milk Oligosaccharides (HMO) Consumption (2019-2030) & (Tons)
Figure 18. Europe Sialylated Human Milk Oligosaccharides (HMO) Consumption (2019-2030) & (Tons)
Figure 19. Japan Sialylated Human Milk Oligosaccharides (HMO) Consumption (2019-2030) & (Tons)
Figure 20. South Korea Sialylated Human Milk Oligosaccharides (HMO) Consumption (2019-2030) & (Tons)
Figure 21. ASEAN Sialylated Human Milk Oligosaccharides (HMO) Consumption (2019-2030) & (Tons)
Figure 22. India Sialylated Human Milk Oligosaccharides (HMO) Consumption (2019-2030) & (Tons)
Figure 23. Producer Shipments of Sialylated Human Milk Oligosaccharides (HMO) by Manufacturer Revenue ($MM) and Market Share (%): 2023
Figure 24. Global Four-firm Concentration Ratios (CR4) for Sialylated Human Milk Oligosaccharides (HMO) Markets in 2023
Figure 25. Global Four-firm Concentration Ratios (CR8) for Sialylated Human Milk Oligosaccharides (HMO) Markets in 2023
Figure 26. United States VS China: Sialylated Human Milk Oligosaccharides (HMO) Production Value Market Share Comparison (2019 & 2023 & 2030)
Figure 27. United States VS China: Sialylated Human Milk Oligosaccharides (HMO) Production Market Share Comparison (2019 & 2023 & 2030)
Figure 28. United States VS China: Sialylated Human Milk Oligosaccharides (HMO) Consumption Market Share Comparison (2019 & 2023 & 2030)
Figure 29. United States Based Manufacturers Sialylated Human Milk Oligosaccharides (HMO) Production Market Share 2023
Figure 30. China Based Manufacturers Sialylated Human Milk Oligosaccharides (HMO) Production Market Share 2023
Figure 31. Rest of World Based Manufacturers Sialylated Human Milk Oligosaccharides (HMO) Production Market Share 2023
Figure 32. World Sialylated Human Milk Oligosaccharides (HMO) Production Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 33. World Sialylated Human Milk Oligosaccharides (HMO) Production Value Market Share by Type in 2023
Figure 34. 3'-Sialyllactose
Figure 35. 6'-Sialyllactose
Figure 36. World Sialylated Human Milk Oligosaccharides (HMO) Production Market Share by Type (2019-2030)
Figure 37. World Sialylated Human Milk Oligosaccharides (HMO) Production Value Market Share by Type (2019-2030)
Figure 38. World Sialylated Human Milk Oligosaccharides (HMO) Average Price by Type (2019-2030) & (US$/Kg)
Figure 39. World Sialylated Human Milk Oligosaccharides (HMO) Production Value by Application, (USD Million), 2019 & 2023 & 2030
Figure 40. World Sialylated Human Milk Oligosaccharides (HMO) Production Value Market Share by Application in 2023
Figure 41. Infant Formula
Figure 42. Food
Figure 43. Others
Figure 44. World Sialylated Human Milk Oligosaccharides (HMO) Production Market Share by Application (2019-2030)
Figure 45. World Sialylated Human Milk Oligosaccharides (HMO) Production Value Market Share by Application (2019-2030)
Figure 46. World Sialylated Human Milk Oligosaccharides (HMO) Average Price by Application (2019-2030) & (US$/Kg)
Figure 47. Sialylated Human Milk Oligosaccharides (HMO) Industry Chain
Figure 48. Sialylated Human Milk Oligosaccharides (HMO) Procurement Model
Figure 49. Sialylated Human Milk Oligosaccharides (HMO) Sales Model
Figure 50. Sialylated Human Milk Oligosaccharides (HMO) Sales Channels, Direct Sales, and Distribution
Figure 51. Methodology
Figure 52. Research Process and Data Source
Research Methodology
Client Requirements
Review and analyze client requirements
Discussion of all the project requirements and queries
Flexibility Check
Project Feasibility Analysis
Finalizing tentative research programme
Structuring project proposal with scope, timeline, and costs
Analyzing Market Dynamics
Determination of key drivers, restraints, challenge, and opportunity
Identifies market needs and trends
Market Size Estimation & Forecast
Estimation of historical data based on secondary and primary data
Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)
Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies
Consideration of geography, region-specific product/service demand for region segments
Consideration of product utilization rates, product demand outlook for segments by application or end-user.
Data Source
Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports,
paid database, press releases, blogs, newsletters,and GIR repositories.
Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts
to verify insights.
Validation
and
triangulation of
secondary and primary source.
Collection of data
Cumulating and collating the essential qualitative and quantitative data
Generation of report in client requested format by research analysts
Reviews by expert analysts
Final quality check
Clarifying queries
Receiving feedback
Ensuring satisfaction
01 Identification of data
This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
02 Evaluation of Market Dynamic
This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
03 Collection of Data
This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
04 Collaboration of Data
This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis
This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.
Companies Mentioned
Chr. Hansen (Jennewein Biotechnologie GmgH) DSM (Glycom A/S) Inbiose Kyowa Hakko Bio GeneChem Inc. FrieslandCampina Ingredients
Purchase Options
Add To Cart
Buy Now
Popular Product Keywords
- We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.Speak to our analyst >>
Our Clients
What We Can Provide?
With better results and higher quality products,Our professional reports can achieve four things:
-
Insight into the industry market information
-
Analyze market development needs
-
Prospects for future development
-
Develop industry investment strategy
-
- Digging deeper into global industry information and providing market strategies.Contact Us >>